Circulating miR-21, miR-146a and Fas ligand respond to postmenopausal estrogen-based hormone replacement therapy – A study with monozygotic twin pairs

Ahtiainen, 2012, Age and estrogen-based hormone therapy affect systemic and local IL-6 and IGF-1 pathways in women, Age (Dordr.), 34, 1249, 10.1007/s11357-011-9298-1 Ahtiainen, 2012, Hormone therapy is associated with better body composition and adipokine/glucose profiles: a study with monozygotic co-twin control design, Menopause, 19, 1329, 10.1097/gme.0b013e31825a3344 Ankarberg-Lindgren, 2008, Twenty-four hours secretion pattern of serum estradiol in healthy prepubertal and pubertal boys as determined by a validated ultra-sensitive extraction RIA, BMC Endocr. Disord., 8, 10.1186/1472-6823-8-10 Bismar, 1995, Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement, J. Clin. Endocrinol. Metab., 80, 3351 Fatouros, 2006, Cell-free plasma DNA as a novel marker of aseptic inflammation severity related to exercise overtraining, Clin. Chem., 52, 1820, 10.1373/clinchem.2006.070417 Finni, 2011, Muscle function in monozygotic female twin pairs discordant for hormone replacement therapy, Muscle Nerve, 44, 769, 10.1002/mus.22162 Franceschi, 2000, Inflamm-aging. An evolutionary perspective on immunosenescence, Ann. N. Y. Acad. Sci., 908, 244, 10.1111/j.1749-6632.2000.tb06651.x Grimby, 1986, Physical activity and muscle training in the elderly, Acta Med. Scand. Suppl., 711, 233 Hamilton, 1999, A species of small antisense RNA in posttranscriptional gene silencing in plants, Science, 286, 950, 10.1126/science.286.5441.950 Jilka, 1992, Increased osteoclast development after estrogen loss: mediation by interleukin-6, Science, 257, 88, 10.1126/science.1621100 Jylhava, 2012, Circulating cell-free DNA is associated with mortality and inflammatory markers in nonagenarians: the Vitality 90+ Study, Exp. Gerontol., 47, 372, 10.1016/j.exger.2012.02.011 Kaprio, 2002, Genetic and environmental factors in complex diseases: the older Finnish Twin Cohort, Twin Res., 5, 358, 10.1375/136905202320906093 Kavathia, 2009, Serum markers of apoptosis decrease with age and cancer stage, Aging (Albany, NY), 1, 652, 10.18632/aging.100069 Kosaka, 2010, Secretory mechanisms and intercellular transfer of microRNAs in living cells, J. Biol. Chem., 285, 17442, 10.1074/jbc.M110.107821 Kumar, 2013, Overexpression of circulating miRNA-21 and miRNA-146a in plasma samples of breast cancer patients, Indian J. Biochem. Biophys., 50, 210 Lasser, 2011, Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages, J. Transl. Med., 9, 10.1186/1479-5876-9-9 Lawrie, 2008, Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma, Br. J. Haematol., 141, 672, 10.1111/j.1365-2141.2008.07077.x Lemoine, 2003, Estrogen receptor alpha mRNA in human skeletal muscles, Med. Sci. Sports Exerc., 35, 439, 10.1249/01.MSS.0000053654.14410.78 Li, 2013, MicroRNA-146a represses mycobacteria-induced inflammatory response and facilitates bacterial replication via targeting IRAK-1 and TRAF-6, PLOS ONE, 8, e81438, 10.1371/journal.pone.0081438 Liu, 2014, Increased exosomal microRNA-21 and microRNA-146a levels in the cervicovaginal lavage specimens of patients with cervical cancer, Int. J. Mol. Sci., 15, 758, 10.3390/ijms15010758 Mogi, 2001, Hypoxia stimulates release of the soluble form of fas ligand that inhibits endothelial cell apoptosis, Lab. Invest., 81, 177, 10.1038/labinvest.3780225 Olivieri, 2012, MiR-146a as marker of senescence-associated pro-inflammatory status in cells involved in vascular remodelling, Age (Dordr.), 35, 1157, 10.1007/s11357-012-9440-8 Olivieri, 2012, Age-related differences in the expression of circulating microRNAs: miR-21 as a new circulating marker of inflammaging, Mech. Ageing Dev., 133, 675, 10.1016/j.mad.2012.09.004 Pacifici, 1991, Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells, Proc. Natl. Acad. Sci. U. S. A., 88, 5134, 10.1073/pnas.88.12.5134 Pacifici, 1989, Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release, Proc. Natl. Acad. Sci. U. S. A., 86, 2398, 10.1073/pnas.86.7.2398 Passeri, 1993, Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal, Endocrinology, 133, 822, 10.1210/endo.133.2.8393776 Phillips, 1993, Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy, Clin. Sci. (Lond.), 84, 95, 10.1042/cs0840095 Pollanen, 2010, Effects of combined hormone replacement therapy or its effective agents on the IGF-1 pathway in skeletal muscle, Growth Horm. IGF Res., 20, 372, 10.1016/j.ghir.2010.07.003 Pollanen, 2007, Muscular transcriptome in postmenopausal women with or without hormone replacement, Rejuvenation Res., 10, 485, 10.1089/rej.2007.0536 Pollanen, 2011, Differential influence of peripheral and systemic sex steroids on skeletal muscle quality in pre- and postmenopausal women, Aging Cell, 10, 650, 10.1111/j.1474-9726.2011.00701.x Qaisar, 2013, Hormone replacement therapy improves contractile function and myonuclear organization of single muscle fibres from postmenopausal monozygotic female twin pairs, J. Physiol., 591, 2333, 10.1113/jphysiol.2012.250092 Ronkainen, 2009, Postmenopausal hormone replacement therapy modifies skeletal muscle composition and function: a study with monozygotic twin pairs, J. Appl. Physiol. (1985), 107, 25, 10.1152/japplphysiol.91518.2008 Ronkainen, 2010, Global gene expression profiles in skeletal muscle of monozygotic female twins discordant for hormone replacement therapy, Aging Cell, 9, 1098, 10.1111/j.1474-9726.2010.00636.x Sayed, 2010, MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand, J. Biol. Chem., 285, 20281, 10.1074/jbc.M110.109207 Serrao, 2001, Neutrophils induce apoptosis of lung epithelial cells via release of soluble Fas ligand, Am. J. Physiol. Lung Cell. Mol. Physiol., 280, L298, 10.1152/ajplung.2001.280.2.L298 Sipila, 2001, Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study, Clin. Sci. (Lond.), 101, 147, 10.1042/CS20000271 Stroun, 1987, Isolation and characterization of DNA from the plasma of cancer patients, Eur. J. Cancer Clin. Oncol., 23, 707, 10.1016/0277-5379(87)90266-5 Suda, 1997, Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing, J. Exp. Med., 186, 2045, 10.1084/jem.186.12.2045 Sugatani, 2013, Down-regulation of miR-21 biogenesis by estrogen action contributes to osteoclastic apoptosis, J. Cell. Biochem., 114, 1217, 10.1002/jcb.24471 Suzuki, 2010, Diazoxide potentiates mesenchymal stem cell survival via NF-kappaB-dependent miR-146a expression by targeting Fas, Am. J. Physiol. Heart Circ. Physiol., 299, H1077, 10.1152/ajpheart.00212.2010 Taganov, 2006, NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses, Proc. Natl. Acad. Sci. U. S. A., 103, 12481, 10.1073/pnas.0605298103 Takahashi, 1994, Human Fas ligand: gene structure, chromosomal location and species specificity, Int. Immunol., 6, 1567, 10.1093/intimm/6.10.1567 Turpeinen, 2008, Determination of aldosterone in serum by liquid chromatography–tandem mass spectrometry, J. Chromatogr. B: Anal. Technol. Biomed. Life Sci., 862, 113, 10.1016/j.jchromb.2007.11.005 Vinciguerra, 2009, Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes, Hepatology, 49, 1176, 10.1002/hep.22737 Wiik, 2005, Oestrogen receptor beta is present in both muscle fibres and endothelial cells within human skeletal muscle tissue, Histochem. Cell Biol., 124, 161, 10.1007/s00418-005-0030-z Xerri, 1997, Fas ligand is not only expressed in immune privileged human organs but is also coexpressed with Fas in various epithelial tissues, Mol. Pathol., 50, 87, 10.1136/mp.50.2.87 Yoshimura, 1989, Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes, J. Immunol., 142, 1956, 10.4049/jimmunol.142.6.1956 Yoshimura, 1989, Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE, FEBS Lett., 244, 487, 10.1016/0014-5793(89)80590-3